Bustos Matilde: Difference between revisions
From Bioblast
Beno Marija (talk | contribs) No edit summary |
Tindle Lisa (talk | contribs) No edit summary |
||
(9 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
{{EAGLE | {{EAGLE | ||
|COST=Member | |COST=Member | ||
|COST=WG3 | |COST WG1=WG1 | ||
|COST WG2=WG2 | |||
|COST WG3=WG3 | |||
|COST WG4=WG4 | |||
}} | |||
{{Person | {{Person | ||
|lastname=Bustos | |lastname=Bustos | ||
|firstname=Matilde | |firstname=Matilde | ||
|title=Dr. | |title=Dr. | ||
[https://orcid.org/0000-0003-2306-9548 ORCID ID] | |||
|institution=Institute Biomedicine of Seville (IBIS) | |institution=Institute Biomedicine of Seville (IBIS) | ||
Lab 212 | Lab 212 | ||
Line 15: | Line 19: | ||
}} | }} | ||
__TOC__ | |||
== Bioenergetics Communications == | |||
::::* Matilde Bustos is Associate Editor of the journal '''[[Bioenergetics Communications]]''' | |||
:::::'''Keywords:''' mitochondrial metabolism, mitochondrial stress, metabolic disorders | |||
==MitoEAGLE== | ==MitoEAGLE== | ||
****: '''Benefits for COST and for the COST Action MitoEAGLE''' | |||
:::: I believe that being member of Mito EAGLE will be an excellent opportunity to improve our knowledge in liver disease. In fact, we have expertise in liver disease and metabolism. Mitochondrial dysfunction is underlying in the progression of several liver pathologies | :::: I believe that being member of Mito EAGLE will be an excellent opportunity to improve our knowledge in liver disease. In fact, we have expertise in liver disease and metabolism. Mitochondrial dysfunction is underlying in the progression of several liver pathologies | ||
The main reason to join MitoEAGLE is to share and increases knowledge about mitochondrial functionality (protocols and techniques). | :::: The main reason to join MitoEAGLE is to share and increases knowledge about mitochondrial functionality (protocols and techniques). | ||
:::: Our lab has murine models with decreased mitochondrial activity. Also, our work involved the study of different cell lines. Finally, we have human liver samples from several liver pathologies. I could contribute to WP3 | :::: Our lab has murine models with decreased mitochondrial activity. Also, our work involved the study of different cell lines. Finally, we have human liver samples from several liver pathologies. I could contribute to WP3 | ||
{{Labelingperson}} |
Latest revision as of 15:58, 29 November 2021
News and Events | Working Groups | Short-Term Scientific Missions | Management Committee | Members |
COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping
Bustos Matilde
MitoPedia topics: EAGLE
COST: Member COST WG1: WG1 COST WG2: WG2 COST WG3: WG3 COST WG4: WG4
Name | Bustos Matilde, Dr. |
---|---|
Institution | Institute Biomedicine of Seville (IBIS)
Lab 212 |
Address | Avda. Manuel Siurot, s/n, 41013 |
City | Sevilla |
State/Province | |
Country | Spain |
[email protected] | |
Weblink | |
O2k-Network Lab |
Bioenergetics Communications
- Matilde Bustos is Associate Editor of the journal Bioenergetics Communications
- Keywords: mitochondrial metabolism, mitochondrial stress, metabolic disorders
MitoEAGLE
- Benefits for COST and for the COST Action MitoEAGLE
- I believe that being member of Mito EAGLE will be an excellent opportunity to improve our knowledge in liver disease. In fact, we have expertise in liver disease and metabolism. Mitochondrial dysfunction is underlying in the progression of several liver pathologies
- The main reason to join MitoEAGLE is to share and increases knowledge about mitochondrial functionality (protocols and techniques).
- Our lab has murine models with decreased mitochondrial activity. Also, our work involved the study of different cell lines. Finally, we have human liver samples from several liver pathologies. I could contribute to WP3
Labels:
Publications
Published | Reference | |
---|---|---|
BEC 2020.1 doi10.26124bec2020-0001.v1 | 2020 | Gnaiger E et al ― MitoEAGLE Task Group (2020) Mitochondrial physiology. Bioenerg Commun 2020.1. https://doi.org/10.26124/bec:2020-0001.v1 |